STD Testing in Outpatient Practices
STOP
1 other identifier
observational
6,771
1 country
1
Brief Summary
National guidelines have recommended routine STD screening (chlamydia and gonorrhea) for sexually active young women under the age of 25. Despite these recommendations, many young women are not being screened for STDs, with some estimates that less than 50% of women receiving health care are screened for chlamydia. Untreated STDs can lead to important sequelae to women's reproductive health including pelvic inflammatory disease, infertility and ectopic pregnancy. One of the most important barriers to widespread STD screening is provider failure to recognize an opportunity for STD screening. The goal of this study is to determine whether offering STD screening (chlamydia and gonorrhea) by a non-physician member of the medical practice (who receives an automated alert indicating STD screening should be offered) will be associated with a higher rate of STD screening in young women attending primary care practices compared to usual care (where a physician offers screening with no electronic alert). This study will be performed in UPMC-affiliated primary care practices (Family Practice, Internal Medicine, OB/GYN, Pediatrics). Practices will be assigned to the intervention or usual care. The intervention will be an auto-task in the electronic medical record to the non-physician/NP/PA medical staff (medical assistants, LPNs, RNs) to offer chlamydia and gonorrhea screening via urine or self-collected vaginal sampling, in an opt-out manner, to eligible women. Practices assigned to the usual care group will not have the intervention. STD screening rates (# women undergoing STD screening/# eligible women) will be compared between the to groups (intervention practices and control practices). Results of this study may be important to guide national STD screening recommendations and will address critical barriers to widespread STD screening.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2017
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 12, 2017
CompletedFirst Submitted
Initial submission to the registry
July 18, 2017
CompletedFirst Posted
Study publicly available on registry
August 11, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 11, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2020
CompletedMarch 10, 2021
March 1, 2021
2.4 years
July 18, 2017
March 9, 2021
Conditions
Outcome Measures
Primary Outcomes (2)
Rate of STD Screening
Rate of screening (Chlamydia and Gonorrhea) in young women attending primary care practices
Day 1
Number of Chlamydia and Gonorrhea infections identified
Day 1
Study Arms (2)
universal opt-out screening for STDs
Patients who present to primary care practices who employee a universal opt-out strategy to medical assistants or nurses
without universal opt-out screening for STDs
Patients who present to primary care practices who do not employee a universal opt-out strategy to medical assistants or nurses
Eligibility Criteria
Young women at risk for STDs
You may qualify if:
- Women ages 15-24 Sexually Active Receiving care in one of the primary care offices affiliated with UPMC selected for this study.
You may not qualify if:
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Pittsburghlead
- CDC Foundationcollaborator
Study Sites (1)
Magee-Womens Hospital of UPMC/associated community clinics
Pittsburgh, Pennsylvania, 15213, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Harold C Wiesenfeld, MD
University of Pittsburgh
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 18, 2017
First Posted
August 11, 2017
Study Start
June 12, 2017
Primary Completion
November 11, 2019
Study Completion
December 30, 2020
Last Updated
March 10, 2021
Record last verified: 2021-03